Ant International Launches Alipay+ Voyager, a Built-in End-to-End AI Travel Companion for Digital Wallet and Super App Users
2.7.2025 08:12:00 CEST | Business Wire | Press Release
With launch partners including Agoda, Fliggy and Trip.com, Ant International introduces Alipay+ Voyager, an AI travel companion integrated into digital wallets for the travel industry to simplify and enhance travel experiences for global consumers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250701160496/en/
A sample user interface of Alipay+ Voyager, which users can access via digital wallets
Alipay+ Voyager combines Ant International's agentic AI capabilities with the galaxy of cross-border travel services offered by OTA partners and 100 million global merchants in Alipay+'s partner ecosystem.
Through its one single AI interface embedded in e-wallets and super apps, Alipay+ Voyager assists travellers, via text or voice in their local language, to complete itinerary planning, booking, and purchasing in-destination merchant offerings with a seamless flow.
Alipay+ Voyager is first launched on three of Asia’s biggest mobile wallets, Alipay (Chinese mainland), AlipayHK (Hong Kong SAR, China) and GCash (the Philippines) ahead of the summer travel peak. It will roll out to more Alipay+ payment partners throughout 2025.
Alipay+, started as a cross-border payment technology solution, now helping 36 leading e-wallets and payment apps with 1.7 billion consumer accounts connect to over 100 million merchants. The Alipay+ Wallet Tech team has been working with e-wallet partners in emerging markets to develop payment, security and growth capabilities and solutions since 2015. Today, the team plans to further build out other agentic AI suites for different industries on Alipay+ GenAI Cockpit, its main AI platform for fintechs.
Driving Global Connectivity and Growth in the Merchant-Wallet-Consumer Ecosystem
The online travel market is expected to grow 10% annually through 2032, with mobile already making up two-thirds of traffic1. Travellers, especially Gen Zs, increasingly favour unique, hyperlocal experiences, using mobile-first, all-in-one solutions to uncover their best options.
Alipay+ Voyager has a number of distinct features:
- Intelligent end-to-end assistance from one single hub in familiar wallets: research, decision and action support before, during and after the trip;
- Real-time global-to-local connections: seamless transitioning to local services like ride-hailing, public transport, shopping, dining and sightseeing;
- Purposeful, forward-looking curation: Voyager AI intuitively understands a user’s preferences, proactively solves problems when there are issues such as flight delays or bad weather, and surfaces hyper-relevant options in real-time before a traveller even asks, all within their home e-wallet;
- A new growth gateway for merchants and OTAs: captures multiple core markets through one easy deployment across the largest regional and global e-wallets.
“Travellers today are using more tech to enhance their trips, and there is a need for the industry to adapt and meet these new and emerging expectations,” said Douglas Feagin, President of Ant International. “By integrating a proactive, always-on AI travel companion within digital wallets that consumers already use frequently, we’re empowering travel and wallet partners with new opportunities to engage travellers in a more relevant, personalised way, through every step of their journey.”
Gil Hazan, Senior Vice President of Strategic Partnerships, Agoda, said: “At Agoda, we are committed to making travel more accessible and seamless for everyone. By integrating our extensive supply network as one of Asia's leading online travel platforms with Alipay+ Voyager's expansive wallet partnerships, we can offer travellers a more convenient and personalized booking experience. This collaboration enables us to reach a broader audience and provide tailored travel solutions that cater to the diverse needs of today's travellers.”
About Ant International
With headquarters in Singapore and main operations across Asia, Europe, the Middle East and Latin America, Ant International is a leading global digital payment, digitisation and financial technology provider. Through collaboration across the private and public sectors, our unified techfin platform supports financial institutions and merchants of all sizes to achieve inclusive growth through a comprehensive range of cutting-edge digital payment and financial services solutions. To learn more, please visit https://www.ant-intl.com/
About Alipay+
Ant International's Alipay+ is a unified wallet gateway with cross-border payment and digitisation services that help connect global merchants to consumers. Consumers enjoy seamless payments, a broad choice of deals and the convenience of digital services using their preferred payment app/e-wallet while travelling abroad. Many small and medium-sized businesses already use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250701160496/en/
Contacts
Scott Lai
scott.lai@ant-intl.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom